Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
Clinical trial NCT05270733 · RECRUITING
Trial details
- NCT number
- NCT05270733
- Sponsor
- University Hospitals Cleveland Medical Center
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2026-12-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.